Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease

Journal of Steroid Biochemistry and Molecular Biology

Volumn 128, Issue 1-2, 2012, Pages 56-61

  Doorenbos, Carolina R C ^a   De Cuba, Milton M ^a   Vogt, Liffert ^b   Kema, Ido P ^a   Van Den Born, Jacob ^a   Gans, Reinold O B ^a   Navis, Gerjan ^a   De Borst, Martin H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Proteinuria; RAAS blockade; Vitamin D binding protein; Vitamin D 3

Indexed keywords

CALCIFEDIOL; CALCITRIOL; INDOMETACIN; LISINOPRIL; ROFECOXIB; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PROTEINURIA; RADIOIMMUNOASSAY; URINARY EXCRETION; VITAMIN BLOOD LEVEL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYCHOLECALCIFEROLS; INDOMETHACIN; KIDNEY FAILURE, CHRONIC; LACTONES; LISINOPRIL; MALE; MIDDLE AGED; PROTEINURIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENIN-ANGIOTENSIN SYSTEM; SULFONES; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN;

EID: 82755182539     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.09.002     Document Type: Article

References (17)

1. C.R. Doorenbos, J. van den Born, G. Navis, and M.H. de Borst Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism Nat. Rev. Nephrol. 5 2009 691 700
2. P. Ravani, F. Malberti, G. Tripepi, P. Pecchini, S. Cutrupi, P. Pizzini, F. Mallamaci, and C. Zoccali Vitamin D levels and patient outcome in chronic kidney disease Kidney Int. 75 2009 88 95
3. S. Pilz, S. Iodice, A. Zitterman, W.B. Grant, and S. Gandini Vitamin D Status and Mortality Risk in CKD: a meta-analysis of prospective studies Am. J. Kidney Dis. 58 2011 374 382
4. C.F. Helvig, D. Cuerrier, C.M. Hosfield, B. Ireland, A.Z. Kharebov, J.W. Kim, N.J. Ramjit, K. Ryder, S.P. Tabash, A.M. Herzenberg, T.M. Epps, and M. Petkovich Dysregulation of renal vitamin D metabolism in the uremic rat Kidney Int. 78 2010 463 472
5. R. Mehrotra, D. Kermah, M. Budoff, I.B. Salusky, S.S. Mao, Y.L. Gao, J. Takasu, S. Adler, and K. Norris Hypovitaminosis D in chronic kidney disease Clin. J. Am. Soc. Nephrol. 3 2008 1144 1151
6. J.M. Barragry, M.W. France, N.D. Carter, J.A. Auton, M. Beer, B.J. Boucher, and R.D. Cohen Vitamin-D metabolism in nephrotic syndrome Lancet 2 1977 629 632 (Pubitemid 8183111)
7. A. Nykjaer, D. Dragun, D. Walther, H. Vorum, C. Jacobsen, J. Herz, F. Melsen, E.I. Christensen, and T.E. Willnow An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3 Cell 96 1999 507 515 (Pubitemid 29106838)
8. J.R. Leheste, B. Rolinski, H. Vorum, J. Hilpert, A. Nykjaer, C. Jacobsen, P. Aucouturier, J.O. Moskaug, A. Otto, E.I. Christensen, and T.E. Willnow Megalin knockout mice as an animal model of low molecular weight proteinuria Am. J. Pathol. 155 1999 1361 1370 (Pubitemid 29488943)
9. A. Nykjaer, J.C. Fyfe, R. Kozyraki, J.R. Leheste, C. Jacobsen, M.S. Nielsen, P.J. Verroust, M. Aminoff, A. de la Chapelle, S.K. Moestrup, R. Ray, J. Gliemann, T.E. Willnow, and E.I. Christensen Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3) Proc. Natl. Acad. Sci. U. S. A. 98 2001 13895 13900 (Pubitemid 33115995)
10. L. Vogt, D. de Zeeuw, A.J. Woittiez, and G. Navis Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients Nephrol. Dial. Transplant. 24 2009 1182 1189
11. W.H. de Jong, K.S. Graham, J.C. van der Molen, T.P. Links, M.R. Morris, H.A. Ross, E.G. de Vries, and I.P. Kema Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry Clin. Chem. 53 2007 1684 1693 (Pubitemid 47340066)
12. K.M. Thrailkill, C.H. Jo, G.E. Cockrell, C.S. Moreau, and J.L. Fowlkes Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J. Clin. Endocrinol. Metab. 96 2011 142 149
13. C.J. Laing, and N.E. Cooke Vitamin D binding protein D. Feldman, J.W. Pike, F.H. Glorieux, Vitamin D 2005 Elsevier Academic Press Burlington, MA pp. 117-134
14. D.D. Bikle, B.P. Halloran, E. Gee, E. Ryzen, and J.G. Haddad Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels J. Clin. Invest. 78 1986 748 752 (Pubitemid 16024811)
15. M. Speeckaert, G. Huang, J.R. Delanghe, and Y.E. Taes Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism Clin. Chim. Acta 372 2006 33 42 (Pubitemid 44286753)
16. M. Kawakami, C.B. Blum, R. Ramakrishnan, R.B. Dell, and D.S. Goodman Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjects J. Clin. Endocrinol. Metab. 53 1981 1110 1116 (Pubitemid 13237540)
17. A.S. Dusso, and M. Tokoumoto Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease Kidney Int. 79 2011 715 729